Cargando…
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
Schizophrenia-spectrum disorders are associated with substantial impairment and disability. Lack of treatment adherence is a major issue, especially in low- and middle-income countries (LMICs). Despite growing evidence supporting second-generation long-acting antipsychotics (LAIs) as an effective st...
Autores principales: | Ostuzzi, Giovanni, Gastaldon, Chiara, Papola, Davide, Barbui, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121849/ https://www.ncbi.nlm.nih.gov/pubmed/35543395 http://dx.doi.org/10.1017/S2045796022000166 |
Ejemplares similares
-
Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
por: Papola, Davide, et al.
Publicado: (2020) -
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023) -
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023) -
Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020) -
Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)